| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/29/2008 | CA2311423C Method for treating hyperlipidemia |
| 01/29/2008 | CA2296720C Use of botulinum toxin in the preparation of a pharmaceutical composition for treating a prostate disorder in a mammal |
| 01/29/2008 | CA2149776C Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 01/24/2008 | WO2008011016A2 Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists |
| 01/24/2008 | WO2008010511A1 Screening method |
| 01/24/2008 | WO2008010315A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | WO2008010223A2 Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| 01/24/2008 | WO2008010222A2 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders |
| 01/24/2008 | WO2008009927A1 Use of fulvestrant and an aromatase inhibitor for treating breast cancer |
| 01/24/2008 | WO2008009866A2 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor |
| 01/24/2008 | WO2008009640A1 New paediatric indications for direct thrombin inhibitors |
| 01/24/2008 | WO2008009589A2 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 01/24/2008 | WO2007088343A3 Granular material comprising water- insoluble inorganic phosphate binders |
| 01/24/2008 | WO2007061874A3 Methods and compositions for use in treating cancer |
| 01/24/2008 | WO2007049265A3 Anti mineralocorticoid therapy of infection |
| 01/24/2008 | WO2005120576A3 Composition and method for improving pancreatic islet cell survival |
| 01/24/2008 | US20080021439 Intradermal cellular delivery using narrow gauge micro-cannula |
| 01/24/2008 | US20080021108 Memory Fixation Accelerator |
| 01/24/2008 | US20080021105 Medicine Capable of Inhibiting Activation of Transcription Factor Klf5 |
| 01/24/2008 | US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities |
| 01/24/2008 | US20080021060 Quinuclidine carbamate derivatives and their use as M3 antagonists |
| 01/24/2008 | US20080021040 Method and composition for treating periodontal disease |
| 01/24/2008 | US20080021016 Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions |
| 01/24/2008 | US20080021006 steroids used as androgen receptor modulators, for the treatment prostate cancer, benign prostatic hyperplasia or breast cancer |
| 01/24/2008 | US20080020073 Use of oligosaccharides to stimulate beta-endorphin production |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080019997 Therapeutic uses of dunaliella powder |
| 01/24/2008 | US20080019991 Carrier Conjugates Of Tnf-Peptides |
| 01/24/2008 | US20080019989 Immunity Adjuvant Containing a Complexed Metal Cation and Vaccine Containing Same |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019981 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 01/24/2008 | US20080019980 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 01/24/2008 | US20080019977 administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |
| 01/24/2008 | US20080019950 Novel hepatocyte-like cells and hepatoblast-like cells derived from hBS cells |
| 01/24/2008 | US20080019917 Compositions Comprising Cells and Magnetic Materials for Targeted Delivery |
| 01/24/2008 | DE60128472T2 Kombinierte tumortherapie auf der basis von distamycin-acryloylderivaten und alkylierungsmitteln Combined tumor therapy on the basis of distamycin acryloylderivaten and alkylating agents |
| 01/24/2008 | CA2777173A1 Improvement of the bioavailability of active substances having an amidine function in medicaments |
| 01/24/2008 | CA2659754A1 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor |
| 01/24/2008 | CA2659521A1 Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| 01/24/2008 | CA2658342A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | CA2657270A1 New paediatric indications for direct thrombin inhibitors |
| 01/24/2008 | CA2656807A1 Early detection and prognosis of colon cancers |
| 01/23/2008 | EP1881327A2 Diagnosis and treatment of malignant neoplasms |
| 01/23/2008 | EP1881065A1 DINO polypetide |
| 01/23/2008 | EP1881007A1 LLR-J24 related proteins |
| 01/23/2008 | EP1880737A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 01/23/2008 | EP1880716A1 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 01/23/2008 | EP1880001A1 Feline probiotic lactobacilli |
| 01/23/2008 | EP1879656A1 Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
| 01/23/2008 | EP1879655A2 Pharmaceutical composition comprising an anti-bacterial agent and an activeingredient selected from carveol, thymol, eugenol, borneol and carvacrol |
| 01/23/2008 | EP1879654A2 Pharmaceutical combination comprenant un agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol and alpha-and beta-ionones |
| 01/23/2008 | EP1879621A2 Active composition for treatment or prevention of problems related to a disturbance of the biological clock |
| 01/23/2008 | EP1879620A2 Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
| 01/23/2008 | EP1879619A2 Analgesic combination of sodium channel blockers with opioid antagonists |
| 01/23/2008 | EP1879618A2 A method for modulating hla class ii tumor cell surface expression with a cytokine mixture |
| 01/23/2008 | EP1879595A2 Compositions and methods for treating hyperproliferative epidermal diseases |
| 01/23/2008 | EP1879591A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders |
| 01/23/2008 | EP1879588A2 Combination therapy |
| 01/23/2008 | EP1879578A2 Methods and compositions for the treatment of urinary incontinence |
| 01/23/2008 | EP1879572A2 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 01/23/2008 | EP1879569A2 Therapeutic combinations for the treatment or prevention of psychotic disorders |
| 01/23/2008 | EP1879449A2 Compositions and methods for skin care |
| 01/23/2008 | EP1610787B1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from tiotropium salts for the treatment of respiratory diseases |
| 01/23/2008 | EP1599169A4 Method for increasing hair growth |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP0986376B1 USE OF A FACTOR Xa INHIBITing oligosaccharide WITH A PLATELET ANTIAGGREGATING AGENT FOR TREATING ARTERIAL THROMBOSIS |
| 01/23/2008 | CN101111266A Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 01/23/2008 | CN101111255A Methods for treating parkinson's disease |
| 01/23/2008 | CN101111247A Preventive or therapeutic agent for herpesvirus-related disease |
| 01/23/2008 | CN101111239A Composition for body fat reduction |
| 01/23/2008 | CN101111235A Methods of using and compositions comprising pde4 modulators for treatment, prevention and management airway inflammation |
| 01/23/2008 | CN101111234A Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders |
| 01/23/2008 | CN101108185A Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 01/23/2008 | CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/23/2008 | CN100363362C Thiazole derivatives as NPY receptor antagonists |
| 01/23/2008 | CN100363005C Composite preparation for treatment of dementia |
| 01/23/2008 | CN100362995C CYP2A enzymes and their use in therapeutic and diagnostic method |
| 01/22/2008 | US7320996 Administering to a cancer patient an indole-2-one derivative containing pyrrole ring as protein kinase inhibitor together with a cyclooxygenase inhibitor to treat the cancer |
| 01/22/2008 | US7320985 Adding a pyridonecarboxylic acid comprising lomefloxacin, norfloxacin, ofloxacin, enoxacin, ciprofloxacin, tosufloxacin, fleroxacin and/or levofloxacin; cinoxacin, sparfloxacin or salt; low temperature; antiinflammatory agents |
| 01/22/2008 | US7320976 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/22/2008 | US7320972 Hypercholesterolemia, cholesterol-associated benign and malignant tumors; hyperlipidemia, arteriosclerosis, and sitosterolemia; 6) (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(2',3',4'-trimethoxybiphenyl-4-yl)azetidin-2-one |
| 01/22/2008 | US7320969 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 01/22/2008 | US7320959 Transgenic aniomal nmodels; screening; administering peptide |
| 01/22/2008 | US7320873 for diagnosing autoimmune disease (rheumatoid arthritis) activity using monoclonal antibodies |
| 01/22/2008 | US7320859 Using nucleoprotein filament complexes to transfer nucleotide sequences into cells; nonviral gene therapy |
| 01/22/2008 | US7320804 Orally administering ferrous sulfate for inhibiting dry cough induced by angiotensin-converting enzyme inhibitors |
| 01/22/2008 | US7320802 Improved pharmacokinetic profiles; bioadhesives |
| 01/22/2008 | US7320786 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 01/22/2008 | US7320785 Compositions and methods for modulation of DARPP-32 phosphorylation |
| 01/22/2008 | US7320679 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| 01/22/2008 | CA2490638C Combination therapy wherein a serotonin reuptake inhibitor is used |
| 01/22/2008 | CA2404120C Use of bradycardiac agents in the treatment of myocardial diseases accompanied by hypertrophy and new drug combinations |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2303807C Bioresorbable compositions for implantable prostheses |
| 01/22/2008 | CA2289914C Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof |
| 01/22/2008 | CA2222676C New pharmaceutical composition with anaesthetic effect |
| 01/17/2008 | WO2008008549A2 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat neoplasia |